Analytical Data
-
基因名
HTN1
- Application
-
别名
HTN1；HIS1；Histatin-1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P15515
-
表达区间
20-57aa
-
氨基酸序列
D SHEKRHHGYR RKFHEKHHSH REFPFYGDYG SNYLYDN
-
分子量
6.9 kDa 6.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
HTN1 (Huntingtin Interacting Protein 1) recombinant protein has gained significant attention in recent years due to its potential implications in neurodegenerative diseases, particularly Huntington's disease (HD). HTN1 encodes a protein that interacts with the mutant huntingtin protein, which is known to form toxic aggregates and lead to neuronal dysfunction and cell death. Understanding the interactions and pathways involving HTN1 is crucial for elucidating the molecular mechanisms underlying HD and identifying potential therapeutic targets. Research efforts have focused on generating recombinant HTN1 protein to study its functional properties, interactions with other proteins, and its role in cellular processes. By employing techniques such as molecular cloning, expression in heterologous systems, and purification, scientists aim to obtain high-quality HTN1 protein for structural and functional analyses. Moreover, exploring the biochemical properties of HTN1 can provide insights into its potential as a biomarker for disease progression and as a target for drug development. As studies continue, the knowledge gained from HTN1 recombinant protein research could contribute to novel therapeutic strategies to mitigate the effects of Huntington's disease and other related neurodegenerative disorders.
